Cochrane Clinical Answers - Access Denied - What are the benefits and harms of sublingual immunotherapy compared with placebo in people with allergic rhinitis?

Question:What are the benefits and harms of sublingual immunotherapy compared with placebo in people with allergic rhinitis?

EXCERPT of full Clinical Answer

This Cochrane Clinical Answer evaluates sublingual immunotherapy in people with allergic rhinitis.

Sorry, it appears that you don't have a current subscription to COCHRANE CLINICAL ANSWERS.

Are you a COCHRANE CLINICAL ANSWERS subscriber?

SUBSCRIBE NOW to read the full answer

A subscription to THE COCHRANE LIBRARY is required.